232 related articles for article (PubMed ID: 26015409)
1. Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.
Trerotola M; Ganguly KK; Fazli L; Fedele C; Lu H; Dutta A; Liu Q; De Angelis T; Riddell LW; Riobo NA; Gleave ME; Zoubeidi A; Pestell RG; Altieri DC; Languino LR
Oncotarget; 2015 Jun; 6(16):14318-28. PubMed ID: 26015409
[TBL] [Abstract][Full Text] [Related]
2. Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis.
Trerotola M; Li J; Alberti S; Languino LR
J Cell Physiol; 2012 Nov; 227(11):3670-7. PubMed ID: 22378065
[TBL] [Abstract][Full Text] [Related]
3. Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions.
Trerotola M; Jernigan DL; Liu Q; Siddiqui J; Fatatis A; Languino LR
Cancer Res; 2013 May; 73(10):3155-67. PubMed ID: 23536555
[TBL] [Abstract][Full Text] [Related]
4. Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer.
Guerra E; Trerotola M; Relli V; Lattanzio R; Tripaldi R; Vacca G; Ceci M; Boujnah K; Garbo V; Moschella A; Zappacosta R; Simeone P; de Lange R; Weidle UH; Rotelli MT; Picciariello A; Depalo R; Querzoli P; Pedriali M; Bianchini E; Angelucci D; Pizzicannella G; Di Loreto C; Piantelli M; Antolini L; Sun XF; Altomare DF; Alberti S
Neoplasia; 2021 Sep; 23(9):898-911. PubMed ID: 34320447
[TBL] [Abstract][Full Text] [Related]
5. Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition.
Remšík J; Binó L; Kahounová Z; Kharaishvili G; Šimecková Š; Fedr R; Kucírková T; Lenárt S; Muresan XM; Slabáková E; Knopfová L; Bouchal J; Král M; Beneš P; Soucek K
Carcinogenesis; 2018 Dec; 39(11):1411-1418. PubMed ID: 30010814
[TBL] [Abstract][Full Text] [Related]
6. Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma.
Ok Atılgan A; Özdemir BH; Yılmaz Akçay E; Tepeoğlu M; Börcek P; Dirim A
Ann Diagn Pathol; 2020 Apr; 45():151480. PubMed ID: 32106037
[TBL] [Abstract][Full Text] [Related]
7. Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion.
Hu S; Delorme N; Liu Z; Liu T; Velasco-Gonzalez C; Garai J; Pullikuth A; Koochekpour S
Mol Cancer; 2010 Feb; 9():30. PubMed ID: 20132547
[TBL] [Abstract][Full Text] [Related]
8. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.
Zeng ZZ; Jia Y; Hahn NJ; Markwart SM; Rockwood KF; Livant DL
Cancer Res; 2006 Aug; 66(16):8091-9. PubMed ID: 16912186
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration.
Meng F; Joshi B; Nabi IR
PLoS One; 2015; 10(5):e0126056. PubMed ID: 25942420
[TBL] [Abstract][Full Text] [Related]
10. Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.
Kacsinta AD; Rubenstein CS; Sroka IC; Pawar S; Gard JM; Nagle RB; Cress AE
Biochem Biophys Res Commun; 2014 Nov; 454(2):335-40. PubMed ID: 25450398
[TBL] [Abstract][Full Text] [Related]
11. Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression.
Zanna P; Trerotola M; Vacca G; Bonasera V; Palombo B; Guerra E; Rossi C; Lattanzio R; Piantelli M; Alberti S
Cancer; 2007 Jul; 110(2):452-64. PubMed ID: 17559145
[TBL] [Abstract][Full Text] [Related]
12. TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.
Wang G; Zhang Z; Ren Y
Int J Clin Exp Pathol; 2015; 8(5):4705-14. PubMed ID: 26191160
[TBL] [Abstract][Full Text] [Related]
13. Astrocytoma adhesion to extracellular matrix: functional significance of integrin and focal adhesion kinase expression.
Rutka JT; Muller M; Hubbard SL; Forsdike J; Dirks PB; Jung S; Tsugu A; Ivanchuk S; Costello P; Mondal S; Ackerley C; Becker LE
J Neuropathol Exp Neurol; 1999 Feb; 58(2):198-209. PubMed ID: 10029102
[TBL] [Abstract][Full Text] [Related]
14. Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model.
Slack-Davis JK; Hershey ED; Theodorescu D; Frierson HF; Parsons JT
Mol Cancer Ther; 2009 Aug; 8(8):2470-7. PubMed ID: 19671741
[TBL] [Abstract][Full Text] [Related]
15. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma.
Tremblay L; Hauck W; Aprikian AG; Begin LR; Chapdelaine A; Chevalier S
Int J Cancer; 1996 Oct; 68(2):164-71. PubMed ID: 8900422
[TBL] [Abstract][Full Text] [Related]
16. Focal adhesion kinase controls prostate cancer progression via intrinsic kinase and scaffolding functions.
Figel S; Gelman IH
Anticancer Agents Med Chem; 2011 Sep; 11(7):607-16. PubMed ID: 21355844
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-beta-1-integrin complex formation.
Liu Y; Kyle E; Lieberman R; Crowell J; Kellof G; Bergan RC
Clin Exp Metastasis; 2000; 18(3):203-12. PubMed ID: 11315093
[TBL] [Abstract][Full Text] [Related]
18. Trop-2 Induces Tumor Growth Through AKT and Determines Sensitivity to AKT Inhibitors.
Guerra E; Trerotola M; Tripaldi R; Aloisi AL; Simeone P; Sacchetti A; Relli V; D'Amore A; La Sorda R; Lattanzio R; Piantelli M; Alberti S
Clin Cancer Res; 2016 Aug; 22(16):4197-205. PubMed ID: 27022065
[TBL] [Abstract][Full Text] [Related]
19. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
[TBL] [Abstract][Full Text] [Related]
20. Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression.
Kaulfuss S; von Hardenberg S; Schweyer S; Herr AM; Laccone F; Wolf S; Burfeind P
Oncogene; 2009 Nov; 28(45):3971-82. PubMed ID: 19701244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
